Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07271238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

Study acronym: INSiGHT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 15, 2026 (before its estimated October 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 12 words
  2. Minor Re-verified, no change to tracked fieldsv7
  3. Minor Primary and study completion pushed from Sep 15, 2026 to Oct 15, 2026v6
  4. Minor Primary and study completion pushed from Aug 15, 2026 to Sep 15, 2026v5
  5. Minor Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 15, 2026 to Mar 3, 2026
    v3
  2. Notable Start date: Jan 15, 2026 to Mar 15, 2026v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to collect data on the usability and integration of the VERAFEYE Imaging and Guidance System in adult patients indicated to undergo a standard of care catheter-based ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). Results from this study may be used to guide development and refinement the VERAFEYE Imaging and Guidance System capabilities.
Trial Details
NCT Number NCT07271238
Lead Sponsor LUMA Vision Ltd.
Conditions
(from sponsor)
Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia
Related terms Atrial Fibrillation, Atrial Flutter
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov